Dingxin Capital

Dingxin Capital Co., Ltd. is a venture capital firm established in 2014 and headquartered in Shenzhen, China, with additional offices in Foshan, Hangzhou, and Dongguan. The firm specializes in early to middle stage, growth stage, and pre A-round investments, with a strong focus on sectors such as healthcare, consumer upgrade, and advanced technology. In the healthcare domain, Dingxin Capital targets high-end innovative medical devices and aims to address significant clinical needs in areas like cardiovascular, cerebrovascular, gastrointestinal, and orthopedic diseases. The firm is comprised of partners with extensive experience from prominent domestic investment institutions, fostering a robust investment management strategy to ensure sustainable growth.

Hui Hu

Founding Partner

Deng Ning

Partner

17 past transactions

Sitrus Technology

Series C in 2023
Sitrus Technology, founded by returnees from overseas, specializes in the development and production of high-speed network connectivity processors and digital signal processor (DSP) chips for the semiconductor industry. The company's innovative chips feature advanced analog and mixed-signal circuits, designed to enhance efficiency and reduce costs for module manufacturers. Sitrus Technology's products play a vital role in high-speed optical communication, serving various sectors including cloud computing, the Internet of Things, big data, 5G connectivity, intelligent manufacturing, and artificial intelligence networks.

Ai Ma Biology

Angel Round in 2023
Ai Ma Biology is a small RNA nucleic acid drug developer, dedicated to the transformation of achievements in the field of biosynthesis.

Semitech

Series C in 2023
Semitech is an intelligent manufacturing system supplier focused on providing integrated manufacturing solutions for high-tech industries.

DHC Medical

Series A in 2022
DHC Medical is an assisted reproductive service provider

IMPACT Therapeutics

Series D in 2022
IMPACT Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and commercializing therapeutics for cancer and other serious diseases. Founded in 2009 and headquartered in Shanghai, China, the company is engaged in several research and development projects, including the development of PARP inhibitors, Wee1 inhibitors, novel DNA damage response agents, and Hedgehog pathway inhibitors. IMPACT Therapeutics aims to create best-in-class drugs with independent intellectual property rights, emphasizing the discovery of targeted anti-cancer therapies based on the principle of synthetic lethality. The company’s management team possesses extensive experience in drug development and management, with a strong background in pharmacology and biology, which supports its mission to provide innovative treatments for patients with life-threatening conditions.

Resnics

Seed Round in 2021
Resnics specializes in the manufacture of storage and network data processor chip solutions tailored for the communications and Internet sectors. The company is bolstered by a skilled technical team comprising experts in networking, storage, and systems, both domestically and internationally. Resnics possesses significant technical expertise in networking, switching, storage, and high-performance CPUs. The company aspires to establish itself as a high-tech innovation leader, focusing on advancing technology to meet the growing demands of data centers for large chip solutions.

Zettasensing

Venture Round in 2020
Zettasensing is a company based in Jingxi Zhongguancun Mentougou Science and Technology Park that specializes in the research and development of mid-to-high-end sensor chips. The company aims to advance traditional analog sensors by creating highly integrated smart digital sensors. Zettasensing focuses on designing advanced analog and mixed-signal integrated circuits, innovative sensing elements, and intelligent algorithms. Their products are engineered to enhance power consumption, performance, size, cost, and integration levels for industrial applications.

Etailor

Series A in 2019
Etailor is an online clothing brand that is committed to the introduction of European and American fit wear. It is a clothing service provider designated by many film and television organizations. Headquartered in Guangzhou, the center of the domestic apparel industry chain, it has a number of stores and central garment factories in Beijing, Shanghai, Guangzhou and Shenzhen. The team consists of senior red tailors and fashion designers with more than 20 years of experience. , Ping An Insurance underwriting, 30 days unconditional repair. Easy to change clothes is also the [Culture + Technology] project supported by the Propaganda Department of Guangdong Province. It is the only clothing company in China that realizes the central factory and ERP data management.

Jifu Medical

Series B in 2019
Shenzhen Jifu Medical Technology Co., Ltd. researches, develops, and services digital medical equipment, which detects the health of the human intestines and stomach. The company’s digestive tract inspection products and accessories include DA SHENG Capsule Endoscope, Receiving Memory, and Cummerbund. Shenzhen Jifu Medical Technology Co., Ltd. was founded in 2011 and is based in Shenzhen, China.

Antaike Medical

Series A in 2018
Antaike Medical is a minimally invasive interventional medical equipment supplier.

Arigin Medical

Series A in 2017
Arigin Medical is a private company engaging as a medical three-dimensional solutions provider. The firm was founded in 2014 and is based in Shanghai, China.

HaoShouBang

Series A in 2017
Provider of outsourcing blue collar human resource services intended for hotel enterprises. The company provides staff training, work flow management and customer relationship management services to hotel enterprises by utilizing its comprehensive software and hardware system and big data platform, enabling users to greatly reduce operation cost and efficiently manage labor.

Jifu Medical

Series A in 2017
Shenzhen Jifu Medical Technology Co., Ltd. researches, develops, and services digital medical equipment, which detects the health of the human intestines and stomach. The company’s digestive tract inspection products and accessories include DA SHENG Capsule Endoscope, Receiving Memory, and Cummerbund. Shenzhen Jifu Medical Technology Co., Ltd. was founded in 2011 and is based in Shenzhen, China.

Biosis Healing

Series B in 2016
Beijing Biosis Healing Biotechnology Co., Ltd. is a Chinese company founded in 2012, specializing in the research, development, production, and sales of biomaterial medical devices. The company focuses on regenerative medicine materials and implantable medical devices used in clinical surgery. Biosis Healing offers innovative products, including regenerative surgical biomaterials, implantable soft tissue repair mesh, and intelligent minimally invasive surgical instruments. A key product is their self-developed non-crosslinked Extracellular Matrix biomaterial, known as SIS material, which aids in the regeneration of tissue defects and provides effective solutions for tissue repair and functional regeneration following surgical procedures.

Biosis Healing

Series A in 2016
Beijing Biosis Healing Biotechnology Co., Ltd. is a Chinese company founded in 2012, specializing in the research, development, production, and sales of biomaterial medical devices. The company focuses on regenerative medicine materials and implantable medical devices used in clinical surgery. Biosis Healing offers innovative products, including regenerative surgical biomaterials, implantable soft tissue repair mesh, and intelligent minimally invasive surgical instruments. A key product is their self-developed non-crosslinked Extracellular Matrix biomaterial, known as SIS material, which aids in the regeneration of tissue defects and provides effective solutions for tissue repair and functional regeneration following surgical procedures.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.